Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol.

Saperstein, S; Edgren, R A; Lee, G J; Jung, D; Fratis, A; Kushinsky, S; Mroszczak, E; Dorr, A

Saperstein, S; Edgren, R A; Lee, G J; Jung, D; Fratis, A; Kushinsky, S; Mroszczak, E; Dorr, A.

Afiliación

Saperstein S; Syntex Laboratories, Inc., Palo Alto, CA.

Contraception ; 40(5): 581-90, 1989 Nov.

Article en En | MEDLINE | ID: mdl-2612166

Asunto(s)

Etinilestradiol/farmacocinética; Mestranol/farmacocinética; Noretindrona/farmacocinética; Adulto; Anticonceptivos Orales Combinados/farmacocinética; Combinación de Medicamentos; Etinilestradiol/sangre; Femenino; Humanos; Noretindrona/sangre; Radioinmunoensayo; Equivalencia Terapéutica

Palabras clave

Contraception; Contraceptive Agents, Estrogen--analysis; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--analysis; Contraceptive Methods--pharmacodynamics; Data Analysis; Ethinyl Estradiol--analysis; Examinations And Diagnoses; Family Planning; Laboratory Examinations And Diagnoses; Norethindrone--analysis; Oral Contraceptives--pharmacodynamics; Research Methodology

Buscar en Google

Imprimir

XML

PubMed Links

Bases de datos: MEDLINE Asunto principal: Etinilestradiol / Mestranol / Noretindrona Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Contraception Año: 1989 Tipo del documento: Article País de afiliación: Canadá

Buscar en Google

Imprimir

XML

PubMed Links